BACKGROUND: Increased attention bias toward drug-related cues over non-drug-related intrinsically pleasant reinforcers is a hallmark of drug addiction. In this study we used the late positive potential (LPP) to investigate whether such increased attention bias toward drug-related relative to non-drug-related cues changes over a protracted period of reduced drug use in treatment-seeking individuals with a cocaine use disorder (CUD). METHODS: Treatment-seeking individuals with CUD and matched healthy controls passively viewed a series of pleasant, neutral and drug-related pictures while their event-related potentials were recorded at baseline (≤ 3 weeks after treatment initiation) and at 6-month follow-up (only CUD). RESULTS: We included 19 treatment-seeking individuals with CUD and 18 matched controls in our analyses. The results showed a reversal in attention bias (i.e., LPP amplitude) from baseline (i.e., drug > pleasant) to follow-up (i.e., pleasant > drug) driven by an increased attentional engagement with pleasant pictures; this LPP reversal was paralleled by a concomitant reduction in self-reported wanting and craving for cocaine in the CUD group. Furthermore, reduced attention bias toward drug-related cues (relative to pleasant cues) was correlated with longer duration of abstinence at baseline, and the extent of its longitudinal reversal was correlated with decreased craving at follow-up, providing support for abstinence as a putative mechanism of this bottom-up attentional change. LIMITATIONS: A limited sample size and the use of the same set of pictures at baseline and follow-up were the major limitations of this study. CONCLUSION: Results collectively indicate that, by tracking with drug abstinence, LPP in response to drug-related relative to pleasant cues may serve as an indicator of clinical progress in treatment-seeking individuals with CUD.
BACKGROUND: Increased attention bias toward drug-related cues over non-drug-related intrinsically pleasant reinforcers is a hallmark of drug addiction. In this study we used the late positive potential (LPP) to investigate whether such increased attention bias toward drug-related relative to non-drug-related cues changes over a protracted period of reduced drug use in treatment-seeking individuals with a cocaine use disorder (CUD). METHODS: Treatment-seeking individuals with CUD and matched healthy controls passively viewed a series of pleasant, neutral and drug-related pictures while their event-related potentials were recorded at baseline (≤ 3 weeks after treatment initiation) and at 6-month follow-up (only CUD). RESULTS: We included 19 treatment-seeking individuals with CUD and 18 matched controls in our analyses. The results showed a reversal in attention bias (i.e., LPP amplitude) from baseline (i.e., drug > pleasant) to follow-up (i.e., pleasant > drug) driven by an increased attentional engagement with pleasant pictures; this LPP reversal was paralleled by a concomitant reduction in self-reported wanting and craving for cocaine in the CUD group. Furthermore, reduced attention bias toward drug-related cues (relative to pleasant cues) was correlated with longer duration of abstinence at baseline, and the extent of its longitudinal reversal was correlated with decreased craving at follow-up, providing support for abstinence as a putative mechanism of this bottom-up attentional change. LIMITATIONS: A limited sample size and the use of the same set of pictures at baseline and follow-up were the major limitations of this study. CONCLUSION: Results collectively indicate that, by tracking with drug abstinence, LPP in response to drug-related relative to pleasant cues may serve as an indicator of clinical progress in treatment-seeking individuals with CUD.
Authors: Ronald N Ehrman; Steven J Robbins; Melissa A Bromwell; Megan E Lankford; John R Monterosso; Charles P O'Brien Journal: Drug Alcohol Depend Date: 2002-07-01 Impact factor: 4.492
Authors: Gillinder Bedi; Kenzie L Preston; David H Epstein; Stephen J Heishman; Gina F Marrone; Yavin Shaham; Harriet de Wit Journal: Biol Psychiatry Date: 2011-04-01 Impact factor: 13.382
Authors: Francesco Versace; Cho Y Lam; Jeffrey M Engelmann; Jason D Robinson; Jennifer A Minnix; Victoria L Brown; Paul M Cinciripini Journal: Addict Biol Date: 2011-10-04 Impact factor: 4.280
Authors: Andreas Heinz; Jana Wrase; Thorsten Kahnt; Anne Beck; Zohra Bromand; Sabine M Grüsser; Thorsten Kienast; Michael N Smolka; Herta Flor; Karl Mann Journal: Alcohol Clin Exp Res Date: 2007-05-04 Impact factor: 3.455
Authors: Nehal P Vadhan; Kenneth M Carpenter; Marc L Copersino; Carl L Hart; Richard W Foltin; Edward V Nunes Journal: Am J Drug Alcohol Abuse Date: 2007 Impact factor: 3.829
Authors: Jorge S Martins; Keanan J Joyner; Denis M McCarthy; David H Morris; Christopher J Patrick; Bruce D Bartholow Journal: Addict Biol Date: 2021-12-07 Impact factor: 4.280
Authors: Heather E Webber; Danielle A Kessler; Emma C Lathan; Margaret C Wardle; Charles E Green; Joy M Schmitz; Scott D Lane; Anka A Vujanovic Journal: Drug Alcohol Depend Date: 2021-07-28 Impact factor: 4.852
Authors: Melvyn Weibin Zhang; Jiang Bo Ying; Guo Song; Daniel S S Fung; Helen E Smith Journal: Int J Environ Res Public Health Date: 2018-04-04 Impact factor: 3.390
Authors: Emily R Perkins; Keanan J Joyner; Christopher J Patrick; Bruce D Bartholow; Robert D Latzman; Colin G DeYoung; Roman Kotov; Ulrich Reininghaus; Samuel E Cooper; Mohammad H Afzali; Anna R Docherty; Michael N Dretsch; Nicholas R Eaton; Vina M Goghari; John D Haltigan; Robert F Krueger; Elizabeth A Martin; Giorgia Michelini; Anthony C Ruocco; Jennifer L Tackett; Noah C Venables; Irwin D Waldman; David H Zald Journal: Dialogues Clin Neurosci Date: 2020-03 Impact factor: 5.986